(Q47985529)

7 February 2018

title

The Biomarkers Consortium: on the critical path of drug discovery (English)

1 reference

7 February 2018

1 reference

1 reference

C A Altar

1

1 reference

7 February 2018

language of work or name

English

0 references

publication date

9 January 2008

1 reference

7 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 February 2018

volume

83

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

361-364

1 reference

7 February 2018

A new era in psychiatric genetics?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Physicians' views of the relative importance of thirty medical innovations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Fit-for-purpose method development and validation for successful biomarker measurement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

The Biomarkers Consortium: public and private sectors working in partnership to improve the public health

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Adiponectin is independently associated with glycosylated haemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

The prospects for "personalized medicine" in drug development and drug therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100471

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100471

1 reference

7 February 2018

1 reference

7 February 2018